46.46.Z - Wholesale of pharmaceutical goods
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
46.90.Z - Non-specialised wholesale trade
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | 50,3 | 8862,5 |
EBITDA | 1,2 | 1,5 | 24,7 |
Short time liabilities | 2,1 | 2,1 | 0,1 |
Equity capital | 2,7 | 53,2 | 1899,2 |
Operating profit (EBIT) | 1,2 | 1,5 | 24,6 |
Assets | 54,8 | 88,7 | 61,8 |
Net profit (loss) | 0,4 | 50,5 | 11 461,6 |
Cash | 1,9 | 0,6 | -67,9 |
Net income from sale | 7,5 | 8,2 | 9 |
Liabilities and provisions for liabilities | 52,2 | 35,5 | -31,9 |
Working assets | 4 | 37,5 | 849 |
Depreciation | 0 | 0 | 136,4 |
% | % | p.p. | |
Profitability of capital | 16,4 | 95 | 78,6 |
Equity capital to total assets | 4,9 | 59,9 | 55 |
Gross profit margin | 7,4 | 612,2 | 604,8 |
EBITDA Margin | 15,9 | 18,2 | 2,3 |
Days | Days | Days | |
Short term commitment turnover cycle | 101 | 93 | -8 |
Current financial liquidity indicator | 1.8950484991073608 | 17.9720401763916 | 16,1 |
Net dept to EBITDA | 40.09068298339844 | 21.884117126464844 | -18,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane